AI for Pharmaceuticals
AI That Respects
the Protocol
Pharmaceutical development is a decade-long, billion-dollar bet governed by the strictest regulations on earth. KriftAI provides the governed, persistent AI infrastructure that pharma organizations need to accelerate development timelines without compromising the regulatory rigor that protects patients and preserves market authorization.
The Pharmaceutical AI Challenge
Speed Without Compromising Safety
Pharmaceutical organizations operate under a regulatory framework where every decision, every data point, and every conclusion must be traceable, reproducible, and defensible. The cost of a compliance failure is not a fine — it is a delayed drug launch measured in hundreds of millions of dollars, or worse, patient harm that could have been prevented.
Generic AI tools have no awareness of GxP requirements, ICH guidelines, or the difference between a Phase II signal and a confirmed adverse event. Using them in pharmaceutical workflows is not just risky — it is a regulatory liability that auditors and inspectors will identify.
Decade-Long Timelines
Drug development data is spread across preclinical systems, clinical trial databases, regulatory submission platforms, and post-market surveillance — with no unified AI layer connecting them.
Mandatory Reporting Deadlines
Adverse event reporting is legally mandated with severe penalties for missed deadlines. Seven days for fatal/life-threatening events. Fifteen days for serious cases. No exceptions.
Multi-Agency Complexity
Regulatory submissions must satisfy FDA, EMA, PMDA, and dozens of national agencies — each with distinct formatting requirements, data standards, and review expectations.
Knowledge Erosion
Research teams turn over between trial phases. Institutional knowledge about why specific endpoints were chosen or why a formulation was abandoned walks out the door with departing scientists.
KriftAI for Pharmaceuticals
Governed AI Infrastructure for Drug Development & Safety
KriftAI gives pharmaceutical organizations AI agents that operate within GxP boundaries, maintain persistent memory across trial phases, enforce regulatory reporting deadlines at the code level, and produce audit-ready documentation for every decision.
Clinical Development Intelligence
KriftAI maintains persistent memory across Phase I through Phase IV trials — years of accumulated data, decisions, and rationale that survive team transitions and organizational restructuring. The AI tracks endpoint evolution, protocol amendments, site performance, and enrollment dynamics as a continuous institutional memory.
When a new team member asks why a secondary endpoint was added in the Phase II amendment, the answer exists in the system — complete with the data that supported the decision, the regulatory feedback that prompted it, and the committee discussion that approved it.
Pharmacovigilance Engine
Automated adverse event detection, classification, and reporting workflow management with mandatory deadline enforcement. The AI monitors incoming safety data from clinical trials, post-market surveillance, literature, and spontaneous reports — flagging potential signals and initiating reporting workflows within regulatory timeframes.
Reporting deadline hard-locks are enforced at the code level. A serious adverse event triggers an automatic countdown and escalation chain. The AI cannot suppress, delay, or reclassify an event to avoid a reporting obligation. This is not a configurable setting — it is an architectural constraint.
Regulatory Submission Automation
eCTD preparation, cross-referencing, and consistency checking across global regulatory agencies. The AI understands the structural requirements of FDA NDAs, EMA MAAs, and PMDA submissions — identifying gaps, inconsistencies, and formatting issues before they become review deficiencies.
Every document generated or reviewed includes a complete audit trail — which source data informed it, which regulatory guidance was applied, and which human reviewers approved it. Submissions are traceable from raw data to final document.
Research Knowledge Continuity
Drug development programs span a decade or more. Teams change. Priorities shift. Institutional memory fragments. KriftAI captures the reasoning behind research decisions — not just the outcomes — creating a persistent knowledge layer that new team members can query to understand the full history of a program.
Why was a particular excipient abandoned? What did the FDA reviewer flag in the pre-IND meeting? Which biomarker strategy was considered and rejected in Phase I? The answers survive team transitions because they are encoded in the system, not in individual memory.
Applications
Across Pharmaceutical Operations
Clinical Trial Data Management
AI-assisted data reconciliation, query management, and site monitoring using governed personas that enforce GCP requirements and protocol-specific data handling rules.
Adverse Event Signal Detection
Continuous monitoring of safety databases, literature, and spontaneous reports for emerging safety signals with automated case assessment and regulatory reporting workflow initiation.
Regulatory Submission Preparation
eCTD assembly, cross-document consistency verification, and gap analysis across Module 1-5 requirements for FDA, EMA, and global health authority submissions.
Drug Interaction Analysis
Literature-grounded drug-drug interaction assessment, metabolic pathway analysis, and concomitant medication risk evaluation with traceable reasoning chains.
Medical Affairs Intelligence
Scientific communication preparation, KOL engagement tracking, and medical information response management with governed approval workflows and regulatory boundary enforcement.
Patent Landscape Analysis
Competitive intelligence on patent filings, freedom-to-operate assessments, and IP strategy support using persistent memory of evolving patent landscapes and litigation history.
Governed AI Agents
Personas Built for Pharma
Each KriftAI persona is configured with deep pharmaceutical domain definitions — encoding GxP expertise, regulatory frameworks, and safety reporting obligations at the code level. A Pharmacovigilance Specialist operates under fundamentally different constraints than a Clinical Development Analyst or Regulatory Coordinator.
Clinical Development Analyst
Trial design evaluation, protocol optimization, and endpoint analysis using persistent memory of program history, regulatory feedback, and competitive landscape data across development phases.
Pharmacovigilance Specialist
Adverse event case processing, signal detection, and periodic safety report preparation with hard-locks on reporting deadlines and automatic escalation chains for serious and fatal events.
Regulatory Affairs Coordinator
Submission planning, eCTD management, and health authority correspondence tracking with governed access to regulatory intelligence databases and agency-specific formatting requirements.
Drug Safety Scientist
Benefit-risk assessment, safety data aggregation, and REMS evaluation using structured pharmacological frameworks and governed access to clinical trial safety databases and post-market surveillance records.
Deployment Options
Your Infrastructure, Your Rules
Deploy KriftAI within your validated infrastructure — patient data and proprietary research never leave your perimeter.
Your Cloud (AWS, Azure, GCP)
Deploy in your own GxP-validated cloud account with your security controls, audit logging, and data residency configurations.
On-Premise
Deploy within your validated data centers for complete control over patient data, clinical trial information, and proprietary research assets.
Air-Gapped
Completely isolated deployment for pre-submission regulatory work, proprietary compound data, and sensitive clinical trial operations.
Managed Cloud
KriftAI manages infrastructure in a dedicated, isolated, GxP-ready environment. Suitable for mid-size pharma and biotech organizations scaling regulatory operations.
AI for Your Pharmaceutical Operations
Pharmaceutical organizations need AI that understands regulatory obligations, respects patient safety, and maintains the audit trail that inspectors demand. Let's discuss how KriftAI can be configured for your clinical development, pharmacovigilance, and regulatory workflows.
Contactez-nous